Igm Biosciences

Developer of engineered IgM antibodies for the treatment of cancer patients

placeMountain View, California, United States calendar_todayFounded 2010 groups181 employees language igmbio.com

Registered entities

Innovation

46 patent families (15 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 6,066 times.

YearFilings
20156
20169
201710
201815
201913
202017
202120
202223
202323
202419
20257
20263

Investor mix

4 investors on record; lead investors include Redmile Group, Janus Henderson Investors, Vivo Capital.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%
Coming soon